BGNE Stock Summary and Trading Ideas (Beigene Ltd. - American Depositary Shares | NASDAQ:BGNE)

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

Beigene Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol BGNE.

As of April 19, 2024, BGNE stock price declined to $129.52 with 246,310 million shares trading.

BGNE has a beta of 1.24, meaning it tends to be more sensitive to market movements. BGNE has a correlation of 0.11 to the broad based SPY ETF.

BGNE has a market cap of $13.53 billion. This is considered a Large Cap stock.

Last quarter Beigene Ltd. - American Depositary Shares reported $634 million in Revenue and -$3.53 earnings per share. This fell short of revenue expectation by $-151,000 and exceeded earnings estimates by $.20.

In the last 3 years, BGNE stock traded as high as $426.56 and as low as $118.18.

The top ETF exchange traded funds that BGNE belongs to (by Net Assets): IBB, FBT, BBH, QQQJ, AVEM.

BGNE has underperformed the market in the last year with a price return of -51.5% while the SPY ETF gained +21.2%. BGNE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.7% and -13.4%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

BGNE support price is $128.92 and resistance is $135.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BGNE stock will trade within this expected range on the day.